Adjuvanted vs High-Dose Flu Vaccines in Older Adults: What New Research Means for Seniors
Every influenza season places older adults at significantly higher risk of severe illness, hospitalization, pneumonia, and death. Adults aged 65 years and older experience a natural decline in immune responsiveness—known as immunosenescence—which reduces the effectiveness of standard influenza vaccines.
